FDA To Delete Ivermectin Statements In Exchange For Lawsuit Dismissal

By Jessica Karins / March 25, 2024 at 9:00 AM
FDA has agreed to delete years-old social media posts and other materials advising against the use of antiparasitic drug ivermectin to treat COVID-19 in exchange for dismissal of a court case against the agency over the earlier messaging, which plaintiffs said overstepped agency authority by interfering with doctors’ right to practice medicine. The dismissal will avoid a broader ruling on the subjects in the case; the plaintiffs had asked the court to declare that FDA “cannot issue statements or directives...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.